Author details

Full Name

Nataliya Zhukova

Affiliation

ORCID

Career Start Year

2010

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37242551	Effect of the Composition of Leuzea and Cranberry Meal Extracts on Metabolic Processes in Norm and Pathology.		2023
37013636	A novel transcriptional signature identifies T-cell infiltration in high-risk paediatric cancer.	Genome Med	2023
37001527	Generation and multi-dimensional profiling of a childhood cancer cell line atlas defines new therapeutic opportunities.	Cancer Cell	2023
36364314	Antihypothyroid Effect of Salidroside.	Molecules	2022
31233827	Ongoing issues with the management of children with Constitutional Mismatch Repair Deficiency syndrome.	Eur J Med Genet	2019
30608896	Functional Repair Assay for the Diagnosis of Constitutional Mismatch Repair Deficiency From Non-Neoplastic Tissue.	J Clin Oncol	2019
30569607	Use of bevacizumab as a single agent or in adjunct with traditional chemotherapy regimens in children with unresectable or progressive low-grade glioma.	Cancer Med	2019
28727518	Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas.	J Clin Oncol	2017
27001570	Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency.	J Clin Oncol	2016
26970559	Clinical and treatment factors determining long-term outcomes for adult survivors of childhood low-grade glioma: A population-based study.	Cancer	2016
25667294	BRAF mutation and CDKN2A deletion define a clinically distinct subgroup of childhood secondary high-grade glioma.	J Clin Oncol	2015
24218181	Favorable survival and metabolic outcome for children with diencephalic syndrome using a radiation-sparing approach.	J Neurooncol	2014
25539912	WNT activation by lithium abrogates TP53 mutation associated radiation resistance in medulloblastoma.	Acta Neuropathol Commun	2014
23598174	Methylation of the TERT promoter and risk stratification of childhood brain tumours: an integrative genomic and molecular study.	Lancet Oncol	2013
23018576	Williams-Beuren Syndrome and Burkitt Leukemia.	Journal of Pediatric Hematology/Oncology	2013
23835706	Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma.	J Clin Oncol	2013
24174164	TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma.	Acta Neuropathol	2013
22144470	Monoallelic expression determines oncogenic progression and outcome in benign and malignant brain tumors.	Cancer Res	2012
20308654	TP53 alterations determine clinical subgroups and survival of patients with choroid plexus tumors.	J Clin Oncol	2010
21056402	A common molecular mechanism underlies two phenotypically distinct 17p13.1 microdeletion syndromes.	Am J Hum Genet	2010